“We applaud the government’s decision to exempt three additional medicines from customs duty for cancer patients. This move will significantly relieve cancer patients by making essential treatments more affordable and accessible. The proposed changes in customs duty on X-ray tubes and flat panel detectors for domestic X-ray machine production are also commendable. These measures will not only benefit patients but also enhance the overall healthcare infrastructure in the country. Such forward-thinking policies are crucial in our collective fight against cancer and improving patient outcomes.”
